This month marks the fifth anniversary of the ROW Foundation’s first grant. On June 17, 2015 we granted an EEG machine (used to diagnosis epilepsy) to the Armenian League Against Epilepsy (ALAE) for use at the Arabkir Pediatric Hospital in Yerevan, Armenia. This machine was a major step forward for the hospital being able to effectively diagnose and develop treatment plans for children with epilepsy.
A Look Back at ROW’s First Partnership
Addressing the Treatment Gap in the DRC
May 26, 2020
COVID-19 and Epilepsy
July 15, 2020
The following year, we expanded the partnership to include regular grants of Roweepra® (levetiracetam USP), which continue to this day.
In 2019, our partnership was further expanded to include an ongoing supply of Subvenite® (lamotrigine USP) anti-seizure medication. Many additional children have benefited from this treatment.
According to Biayna Sukhudyan, Chief of Neurology and Epilepsy Service, “The Arabkir Pediatric Hospital is privileged to be a multi-grantee of ROW Foundation. … The modern video-EEG equipment gave a start to the development of epilepsy surgery in the country. Thanks to this long-lasting partnership many Armenian children with epilepsy have been successfully treated.”
Dr. Paul Regan, who awarded the initial grants on behalf of ROW, recalls, “It was the dedication of the people there – both medical providers and patients – that moved us to make those grants. And it’s been such dedication that has allowed us to make ongoing grants of equipment and medication to multiple sites in Armenia. We look forward to ongoing, fruitful partnerships with our friends there.”
Major Milestone!
This past month, ROW achieved a major milestone, surpassing 100,000 cumulative “patient prescription months” of medication granted. These medication grants go to areas with large treatment gaps and provide life-changing opportunities for people who have suffered from the physical effects of seizures as well as high levels of stigma and discrimination.
To ROW, each of these patient prescription months represents an adult, young person, or child who has another month with access to medication that control their seizures. For many, this makes a transformational difference in their lives. Thank you for being a part of this!
If you would like to help ROW establish and extend our partnerships with epilepsy-related organizations you can get in touch with us by email at: lori.hairrell@rowpharma.org.
